跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEMEX POWDER FOR SOLUTION FOR INJECTION 100MG/VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
PEMEX POWDER FOR SOLUTION FOR INJECTION 100MG/VIAL
Approved
THERAPEUTIC
PEMEX POWDER FOR SOLUTION FOR INJECTION 100MG/VIAL
JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD.
🇸🇬 Health Sciences Authority
Approval Date
Feb 8, 2019
Approval ID
5104bbc0c2ea4602
Company
JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD.
Type
Therapeutic
Approval Details
Approval Id
5104bbc0c2ea4602
Drug Name
PEMEX POWDER FOR SOLUTION FOR INJECTION 100MG/VIAL
Product Name
PEMEX POWDER FOR SOLUTION FOR INJECTION 100MG/VIAL
Approval Number
SIN15622P
Approval Date
2019-02-08
Registrant
DCH AURIGA SINGAPORE
Licence Holder
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
L01BA04
Atc Item Name
pemetrexed
Pharma Manufacturer Name
APEX PHARMA MARKETING PTE. LTD.
Company Detail Path
/organization/apex-pharma-marketing-pte-ltd
Active Ingredients
PEMETREXED DISODIUM HEMIPENTAHYDRATE 120.8mg eqv PEMETREXED
100mg
PEMETREXED DISODIUM HEMIPENTAHYDRATE 120.8 MG EQV PEMETREXED
100 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 8, 2019
Approval ID
5104bbc0c2ea4602
Type
Therapeutic
Back to HSA Approvals
